Record NNP B-NP O
date NN I-NP O
: : O O
2065-06-27 CD O B-DATE
HPI NNP B-NP O
: : O O
51 CD B-NP B-AGE
yo NNP I-NP O
F NNP I-NP O
with IN B-PP O
HTN NNP B-NP O
, , O O
DM NNP B-NP O
, , O O
CAD NNP B-NP O
, , O O
gastritis NN B-NP O
, , O O
depression NN B-NP O
, , O O
s/p VBD B-VP O
CVA NNP B-NP O
returns NNS I-NP O
for IN B-PP O
f/u NN B-NP O
. . O O
Very RB B-ADJP O
noncompliant JJ I-ADJP O
with IN B-PP O
meds NNS B-NP O
and CC I-NP O
appts NNS I-NP O
Today NN B-NP O
c/o NN I-NP O
significant JJ I-NP O
fatigue NN I-NP O
. . O O
Also RB O O
occ NNP B-NP O
has VBZ B-VP O
left VBN I-VP O
sided VBN I-VP O
chest NN B-NP O
pressure NN I-NP O
and CC O O
DOE. NNP B-NP O
In IN B-PP O
the DT B-NP O
past NN I-NP O
she PRP B-NP O
c/o VBP B-VP O
orthopnea NN B-NP O
and CC O O
this DT B-NP O
is VBZ B-VP O
unchanged JJ B-ADJP O
. . O O
CP CD O O
comes VBZ B-VP O
unrelated JJ B-ADJP O
to TO B-PP O
exertion NN B-NP O
. . O O
No DT B-NP O
n/v NN I-NP O
or CC I-NP O
radiation/diaphoresis NN I-NP O
. . O O
In IN B-PP O
terms NNS B-NP O
of IN B-PP O
s/o NN B-NP O
TIA NNP I-NP O
, , O O
she PRP B-NP O
denies VBZ B-VP O
dizziness NN B-NP O
, , O O
falls VBZ B-VP O
, , O O
visual JJ B-NP O
changes NNS I-NP O
, , O O
ataxia NN B-NP O
, , O O
no DT B-NP O
syncope NN I-NP O
or CC I-NP O
presyncope NN I-NP O
, , O O
no DT B-NP O
other JJ I-NP O
focal JJ I-NP O
neurologic NN I-NP O
sx NN I-NP O
, , O O
she PRP B-NP O
does VBZ B-VP O
get VB I-VP O
frquent JJ B-NP O
headaches NNS I-NP O
. . O O
Problems NNS B-NP O
HTN . O O
DM . O O
CAD NN B-NP O
: : O O
-EKG JJ B-ADJP O
with IN B-PP O
LVH NNP B-NP O
and CC I-NP O
repol NN I-NP O
abnlity NN I-NP O
. . O O
-Stress NN B-NP O
echo NN I-NP O
( -LRB- I-NP O
) -RRB- I-NP O
Limited NNP I-NP O
, , O O
only RB B-NP O
able JJ I-NP O
to TO B-VP O
walk VB I-VP O
0'47" CD B-NP O
. . B-PP O
MHR NNP B-NP O
122 CD I-NP O
( -LRB- I-NP O
72 CD I-NP O
%predicted VBN I-NP O
) -RRB- I-NP O
, , O O
BP NNP B-NP O
230/100 CD I-NP O
. . O O
Stopped NNP B-NP O
2/2 CD I-NP O
dizziness NN I-NP O
, , O O
SOB NNP B-NP O
and CC O O
SSCP. NNP B-NP O
EKG NNP I-NP O
shwed VBD B-VP O
1 CD B-NP O
mm CD I-NP O
ST NNP I-NP O
depressions NNS I-NP O
in IN B-PP O
II NNP B-NP O
, , O O
III NNP B-NP O
, , O O
F NNP B-NP O
, , O O
V5-6 NNP B-NP O
. . I-NP O
Read NNP I-NP O
as IN B-PP O
c/w JJ B-ADJP O
but CC O O
not RB B-ADJP O
diagnostic JJ I-ADJP O
of IN B-PP O
ischemia NN B-NP O
. . O O
Echo NNP B-NP O
showed VBD B-VP O
baseline NN B-NP O
EF NN I-NP O
of IN B-PP O
60 CD B-NP O
% NN I-NP O
with IN B-PP O
no DT B-NP O
RWMA. NNP I-NP O
After IN B-PP O
exercise NN B-NP O
there EX B-NP O
was VBD B-VP O
minor JJ B-NP O
nonspecific JJ I-NP O
inferoposterior JJ I-NP O
WMA. NNP I-NP O
Read NNP I-NP O
as IN B-PP O
no DT B-NP O
evidence NN I-NP O
of IN B-PP O
inducible JJ B-NP O
ischenia NN I-NP O
( -LRB- O O
but CC O O
low JJ B-NP O
sensitivity NN I-NP O
2/2 VBD B-VP O
low JJ B-NP O
MHR NN I-NP O
) -RRB- O O
HX NN B-NP O
OF IN B-PP O
GASTRITIS NNP B-NP O
BY NNP I-NP O
UGIS NNP I-NP O
H NNP I-NP O
PYLORI NNP I-NP O
+ . O O
S/P NNP B-NP O
TAH NNP I-NP O
2/2 CD I-NP O
FIBROIDS NNS I-NP O
OA NN B-NP O
Depression NN B-NP O
Asthma . O O
s/p NN B-NP O
CVA NNS I-NP O
Medications NNS B-NP O
Humulin NNP B-NP O
70/30 CD I-NP O
60 CD I-NP O
UNITS NNP I-NP O
qpm NN I-NP O
x NN I-NP O
30 CD B-NP O
days NNS I-NP O
Insulin NNP B-NP O
REGULAR NNP I-NP O
HUMAN NNP I-NP O
3 CD I-NP O
UNITS NNP I-NP O
SC NNP I-NP O
AC+HS NNP I-NP O
, , O O
use NN B-NP O
per IN B-PP O
sliding VBG B-VP O
scale-2U JJ B-ADJP O
if IN B-PP O
150-200 CD B-NP O
, , O O
4U IN B-ADVP O
if IN B-PP O
200-250 CD B-NP O
, , O O
6U JJ B-ADJP O
250-300 CD B-NP O
, , O O
8U CD B-NP O
300-350 CD I-NP O
Protonix NNP B-NP O
( -LRB- I-NP O
PANTOPRAZOLE NN I-NP O
) -RRB- I-NP O
40MG . I-NP O
TABLET NNP I-NP O
EC NNP I-NP O
take VBP B-VP O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QD . O O
Trazodone DT B-NP O
50MG JJ I-NP O
TABLET NNP I-NP O
take NN I-NP O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
qhs NNS I-NP O
PRN NNP B-NP O
insomna . O O
Naprosyn NNP B-NP O
( -LRB- I-NP O
NAPROXEN NNP I-NP O
) -RRB- I-NP O
500MG . I-NP O
TABLET NNP I-NP O
take VB B-VP O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
BID . O O
Polytrim NN B-NP O
( -LRB- I-NP O
TRIMETHOPRIM/POLYMYXIN NNP I-NP O
B NNP I-NP O
SULFATE NNP I-NP O
) -RRB- I-NP O
1 CD I-NP O
DROP NNP I-NP O
OU NNP I-NP O
Q4-6H NNP I-NP O
x NN I-NP O
7 CD B-NP O
days NNS I-NP O
Proventil NN B-NP O
INH NNP I-NP O
2 CD I-NP O
PUFFS NNP I-NP O
INH NNP I-NP O
Q NNP I-NP O
6 CD I-NP O
H NNP I-NP O
PRN NNP I-NP O
SOB NNP I-NP O
, , O O
PRN NNP B-NP O
: : O O
SOB/WHEEZING VBG B-SBAR O
Azmacort NNP B-NP O
INH NNP I-NP O
2 CD I-NP O
PUFF NNP I-NP O
AER NNP I-NP O
BID NNP I-NP O
Glucophage NNP B-NP O
500 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
BID NNP I-NP O
Lipitor NNP B-NP O
40 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
Zestoretic NNP B-NP O
( -LRB- I-NP O
LISINOPRIL/HYDROCHLOROTHIAZIDE NNP I-NP O
) -RRB- I-NP O
20-25 CC I-NP O
TABLET NNP I-NP O
take VBP B-VP O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QD . O O
Ecasa NNP B-NP O
( -LRB- I-NP O
ASPIRIN NNP I-NP O
ENTERIC NNP I-NP O
COATED NNP I-NP O
) -RRB- I-NP O
325MG JJ I-NP O
TABLET NNP I-NP O
EC NNP I-NP O
take VBP B-VP O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QD . O O
Clarinex NNP B-NP O
( -LRB- I-NP O
DESLORATADINE NNP I-NP O
) -RRB- I-NP O
5MG VBP I-NP O
TABLET NNP I-NP O
take VB B-VP O
1 CD B-NP O
Tablet( NN I-NP O
s VBZ B-VP O
) -RRB- B-NP O
PO NN I-NP O
QD . O O
Plavix NNP B-NP O
( -LRB- I-NP O
CLOPIDOGREL NN I-NP O
) -RRB- I-NP O
75 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
QD . O O
Paxil NNP B-NP O
( -LRB- I-NP O
PAROXETINE NN B-NP O
) -RRB- I-NP O
20 CD I-NP O
MG NNP I-NP O
( -LRB- I-NP O
20MG JJ I-NP O
TABLET NNP I-NP O
take NN I-NP O
1 CD B-NP O
) -RRB- I-NP O
PO NN I-NP O
QD . O O
Atenolol IN B-PP O
50 CD B-NP O
MG NN I-NP O
( -LRB- I-NP O
50MG JJ I-NP O
TABLET NNP I-NP O
take NN I-NP O
1 CD B-NP O
) -RRB- I-NP O
PO NN I-NP O
QD . O O
Flucoconzole NNP B-NP O
150 CD I-NP O
MG NNP I-NP O
PO NNP I-NP O
x1 NNP I-NP O
x NN I-NP O
1 CD B-NP O
day NN I-NP O
Lotrimin NNP B-NP O
1 CD I-NP O
% NN I-NP O
CREAM NNP I-NP O
( -LRB- I-NP O
CLOTRIMAZOLE NN I-NP O
1 CD I-NP O
% NN I-NP O
CREAM NN I-NP O
) -RRB- I-NP O
1 CD I-NP O
APPLICATION NN I-NP O
TOP NNP I-NP O
QD NNP I-NP O
, , O O
apply VB B-VP O
to TO B-PP O
vaginal JJ B-NP O
area NN I-NP O
( -LRB- B-VP O
external JJ B-NP O
) -RRB- I-NP O
qd JJ I-NP O
prn NN I-NP O
itch NN I-NP O
Insulin NNP B-NP O
70/30 CD I-NP O
( -LRB- I-NP O
HUMAN NNP B-PP O
) -RRB- B-NP O
30 CD I-NP O
U/30 IN B-PP O
U NNP B-NP O
SC NNP I-NP O
QAM/Qpm . O O
EXAM NNP B-NP O
: : O O
VS NNP B-NP O
138/8 CD I-NP O
0 CD I-NP O
HR NNP I-NP O
72 CD I-NP O
Neck NNP B-NP O
No DT B-NP O
JVD NN I-NP O
No DT B-NP O
thyromegaly NN I-NP O
No DT B-NP O
carotid NN I-NP O
bruits NNS I-NP O
Cor NNP B-NP O
RRR NNP I-NP O
, , O O
S1S2 NNP B-NP O
, , O O
2/6 CD B-NP O
sys NNS I-NP O
M NNP B-NP O
at IN B-PP O
RUSB NNP B-NP O
Lungs NNP B-NP O
CTA NNP I-NP O
bl NN I-NP O
, , O O
no DT B-NP O
crackles/wheezes NNS I-NP O
Abd NNP B-NP O
Soft NNP I-NP O
NTND NNP I-NP O
+BS . O O
Ext JJ B-NP O
No DT I-NP O
c/c/e NN I-NP O
NEURO NNP B-NP O
: : O O
PERRL. NNP B-NP O
Facial NNP I-NP O
asymmetry NN I-NP O
, , O O
unable JJ B-ADJP O
to TO B-VP O
smile VB I-VP O
or CC I-VP O
raise VB I-VP O
eyebrow NN B-NP O
on IN B-PP O
L, NNP B-NP O
tongue NN I-NP O
deviates NNS I-NP O
to TO B-PP O
R. NNP B-NP O
Strength NNP I-NP O
4/5 VBD B-VP O
LUE NNP B-NP O
extensors NNS I-NP O
, , O O
o/w JJ B-NP O
5/5 CD I-NP O
throughout IN I-NP O
. . I-NP O
Normal NNP I-NP O
gait NN I-NP O
. . O O
Unchanged JJ B-ADJP O
fr IN B-PP O
previous JJ B-NP O
A/P NNP B-NP O
: : O O
53 CD B-NP B-AGE
F NNP I-NP O
with IN B-PP O
MMP NNP B-NP O
incl IN B-PP O
DM NNP B-NP O
, , O O
high JJ B-NP O
chol NN I-NP O
, , O O
depression NN B-NP O
, , O O
s/p JJ B-NP O
TIA NNP I-NP O
, , O O
noncompliance NN B-NP O
, , O O
for IN B-PP O
f/u NN B-NP O
1 CD B-NP O
) -RRB- I-NP O
Recent JJ I-NP O
possible JJ I-NP O
HIV NN I-NP O
exposure NN I-NP O
: : O O
Neg NNP B-NP O
HIV NNP I-NP O
and CC O O
other JJ B-NP O
STDs NNS I-NP O
, , O O
need VBP B-VP O
to TO I-VP O
recheck VB I-VP O
6 CD B-NP O
mos NN I-NP O
after IN B-PP O
exposure NN B-NP O
in IN B-PP O
12/65 CD B-NP B-DATE
2 CD B-NP O
) -RRB- I-NP O
DM . O O
: : O O
--Now JJ B-ADJP O
on IN B-PP O
Humulin NNP B-NP O
70/30 CD I-NP O
at IN B-PP O
60qam NN B-NP O
and CC O O
30 CD B-NP O
qpm NN I-NP O
after IN B-PP O
off RB B-NP O
for IN B-PP O
several JJ B-NP O
mos NN I-NP O
. . O O
Last JJ B-NP O
A1c NNP I-NP O
was VBD B-VP O
13.9 CD B-NP O
. . O O
--Cont JJ B-NP O
glucophage NN I-NP O
500 CD B-NP O
bid NN I-NP O
--cont JJ B-NP O
ASA NNP I-NP O
, , O O
statin NN B-NP O
--at JJ B-NP O
next JJ I-NP O
visit NN I-NP O
will MD B-VP O
schedule VB I-VP O
eye NN B-NP O
exam NN I-NP O
and CC I-NP O
recheck NN I-NP O
A1C . O O
3)NEURO-s/p JJ B-NP O
CVA NNP I-NP O
, , O O
did VBD B-VP O
not RB I-VP O
f/u VB I-VP O
with IN B-PP O
neurology NN B-NP O
but CC O O
will MD B-VP O
resched VBN I-VP O
appt NN B-NP O
today NN I-NP O
. . O O
ASA NNP B-NP O
325 CD I-NP O
qd NN I-NP O
, , O O
Plavix NNP B-NP O
75 CD I-NP O
mg NN I-NP O
PO NN I-NP O
QD. . O O
4)CV-Recent JJ B-NP O
stress NN I-NP O
echo VBP B-VP O
with IN B-PP O
low JJ B-NP O
sensitivity NN I-NP O
given VBN B-NP O
poor JJ I-NP O
exercise NN I-NP O
tolerance NN I-NP O
but CC O O
nondiagnostic JJ B-ADJP O
of IN B-PP O
ischemia NN B-NP O
. . O O
HTN '' O O
poorly RB B-NP O
controlled VBN I-NP O
likely JJ I-NP O
bc NN I-NP O
pt VBD B-VP O
not RB O O
compliant JJ B-ADJP O
with IN B-PP O
meds NNS B-NP O
. . O O
--Restart NN B-NP O
Atenolol NNP I-NP O
at IN B-PP O
25 CD B-NP O
qd NN I-NP O
, , O O
likely JJ B-NP O
need NN I-NP O
to TO B-VP O
titrate VB I-VP O
up RP B-PRT O
, , O O
used VBN B-VP O
to TO I-VP O
be VB I-VP O
on IN B-PP O
100 CD B-NP O
. . O O
Cont NNP O O
Lisinopril NNP O O
20/HCTZ IN B-PP O
25 CD B-NP O
qd NN I-NP O
. . O O
--Cont JJ B-NP O
Lipitor NNP I-NP O
40 CD I-NP O
mg NN I-NP O
qd NN I-NP O
, , O O
will MD B-VP O
check VB I-VP O
LFTs NNP B-NP O
and CC O O
lipid JJ B-NP O
panel NN I-NP O
in IN B-PP O
6-8 CD B-NP O
weeks NNS I-NP O
--Cont JJ B-NP O
ASA NNP I-NP O
325 CD I-NP O
qd . O O
--Check NN B-NP O
EKG NNP I-NP O
and CC O O
resched VBD B-VP O
adenosine NN B-NP O
MIBI IN B-PP O
which WDT B-NP O
she PRP B-NP O
has VBZ B-VP O
missed VBN I-VP O
multiple JJ B-NP O
times NNS I-NP O
--check NN B-NP O
chem NN I-NP O
7 CD B-NP O
given VBN I-NP O
recent JJ I-NP O
restart NN I-NP O
BP NNP I-NP O
meds NNS I-NP O
5)PSYCH-Depression CD B-NP O
. . O O
Cont NNP O O
Celexa NNP O O
to TO B-PP O
40 CD B-NP O
qd NN I-NP O
6)PULM-Asthma DT B-NP O
. . I-NP O
Cont NNP I-NP O
albuterol NN I-NP O
and CC I-NP O
asthmacort NN I-NP O
7)GI-GERD. DT B-NP O
Cont NNP I-NP O
Protonix NNP I-NP O
8)Fatigue NN B-NP O
: : O O
check NN B-NP O
TSH NNP I-NP O
and CC I-NP O
CBC NNP I-NP O
9) CD B-NP O
Health NNP I-NP O
Maint NNP I-NP O
: : O O
--Overdue JJ B-ADJP O
for IN B-PP O
PAP NNP B-NP O
( -LRB- I-NP O
last JJ B-NP O
3 CD I-NP O
yrs NNS I-NP O
ago IN B-PP O
) -RRB- B-NP O
, , O O
will MD B-VP O
schedule VB I-VP O
--Overdue JJ B-ADJP O
for IN B-PP O
Mammo NNP B-NP O
( -LRB- I-NP O
last JJ B-NP O
3 CD I-NP O
yrs NNS I-NP O
ago IN B-PP O
) -RRB- B-NP O
, , O O
will MD B-VP O
schedule VB I-VP O
--check NN B-NP O
chol,LFTs NN I-NP O
, , O O
renal JJ B-NP O
fxn NN I-NP O
, , O O
cbc NN B-NP O
8)F/u NN B-NP O
in IN B-PP O
1 CD B-NP O
mo NN I-NP O
Results NNS B-NP O
06/27/2065 CD B-NP B-DATE
NA NNP I-NP O
137 CD I-NP O
, , O O
K NNP B-NP O
3.9 CD I-NP O
, , O O
CL NN B-NP O
97 CD I-NP O
( -LRB- I-NP O
*) NN I-NP O
, , O O
CO2 NNP B-NP O
30 CD I-NP O
, , O O
BUN NNP B-NP O
12 CD I-NP O
, , O O
CRE NNP B-NP O
0.7 CD I-NP O
, , O O
GLU NNP B-NP O
372 CD I-NP O
( -LRB- I-NP O
*) NN I-NP O
, , O O
CA NNP B-NP O
9.6 CD I-NP O
, , O O
TSH NNP B-NP O
1.798 CD I-NP O
, , O O
HCT NNP B-NP O
41.2 CD I-NP O
Ione NN B-NP B-DOCTOR
Kerr NNP I-NP I-DOCTOR
, , O O
M.D. NNP B-NP O
== NN B-NP O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
Preceptor NNP B-NP O
's POS B-NP O
Note NNP I-NP O
== NNP I-NP O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
= SYM O O
I PRP B-NP O
have VBP B-VP O
discussed VBN I-VP O
this DT B-NP O
patient NN I-NP O
with IN B-PP O
Dr. NNP B-NP O
Kerr NNP I-NP B-DOCTOR
and CC O O
agree VB B-VP O
with IN B-PP O
above JJ B-ADJP O
. . O O
Diane NNP B-NP B-DOCTOR
Rhonda NNP I-NP I-DOCTOR
Welsh NNP I-NP I-DOCTOR
, , O O
M.D. NNP B-NP O
